Takeda Appeals Win For Teva In Generic Prevacid Case

By Tina Peng

Law360, New York (November 17, 2009, 5:25 PM ET) -- Takeda Pharmaceutical Co. Ltd. is appealing its loss in a patent battle with Teva Pharmaceutical Industries Ltd. over a generic version of the acid reflux drug Prevacid.

Takeda filed a notice Tuesday that it was appealing to the U.S. Court of Appeals for the Federal Circuit the final judgment and order, issued by Judge Sue L. Robinson of the U.S. District Court for the District of Delaware in Teva's favor earlier in November, after she concluded that Takeda had failed to prove infringement on the final...
To view the full article, take a free trial now.

Already a subscriber? Click here to login

You must correct or enter the following before you can submit this form:

All fields required

  5. Required

Only Law360 gives you:

Non-stop coverage of high-stakes litigation across 30 practices

Real-time tracking and reports on 10,000+ companies, firms and industries

Over 80,000 attorney profiles with neutral data collected from active lawsuits

Research tools to find cases, court documents, attorneys and companies

Customized feeds and alerts that can easily be shared with colleagues

In-depth expert analysis from high-profile attorneys at top firms

Access to our vault with over 75,000 original articles